Cornerstone Wealth Group LLC Grows Stock Holdings in Cigna Group $CI

Cornerstone Wealth Group LLC grew its holdings in Cigna Group (NYSE:CI) by 4.1% during the 2nd quarter, Holdings Channel reports. The fund owned 3,410 shares of the health services provider’s stock after purchasing an additional 133 shares during the period. Cornerstone Wealth Group LLC’s holdings in Cigna Group were worth $1,127,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the business. Family Legacy Inc. boosted its holdings in shares of Cigna Group by 0.5% in the 1st quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after acquiring an additional 31 shares during the last quarter. Impact Investors Inc boosted its holdings in shares of Cigna Group by 1.6% in the 1st quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after acquiring an additional 31 shares during the last quarter. Mission Wealth Management LP boosted its holdings in shares of Cigna Group by 1.5% in the 1st quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after acquiring an additional 32 shares during the last quarter. Westend Capital Management LLC boosted its holdings in shares of Cigna Group by 8.1% in the 1st quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after acquiring an additional 32 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC boosted its holdings in shares of Cigna Group by 26.8% in the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after acquiring an additional 34 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

CI opened at $295.60 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $78.90 billion, a price-to-earnings ratio of 16.14, a PEG ratio of 0.88 and a beta of 0.45. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88. The firm’s fifty day simple moving average is $295.25 and its two-hundred day simple moving average is $308.92.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CI. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Truist Financial set a $375.00 target price on shares of Cigna Group in a research note on Tuesday, September 2nd. Robert W. Baird set a $372.00 target price on shares of Cigna Group in a research note on Thursday, August 14th. Finally, Wells Fargo & Company increased their target price on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $372.69.

Insider Activity

In other news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.